Core Viewpoint - The medical beauty sector experienced a decline of 1.37% on December 23, with Ai Meike leading the drop, while the overall market indices showed slight increases [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3919.98, up 0.07% [1] - The Shenzhen Component Index closed at 13368.99, up 0.27% [1] - The medical beauty sector saw a net outflow of 64.78 million yuan from main funds, while retail investors contributed a net inflow of 39.45 million yuan [1] Group 2: Individual Stock Performance - Jinbo Biological (code: 920982) closed at 249.76, with a gain of 1.33% and a trading volume of 88,613.2 hands, totaling 218 million yuan [1] - ST Meigu (code: 000615) closed at 4.18, down 0.95% with a trading volume of 215,700 hands, totaling 9.28 million yuan [1] - Huaxi Biological (code: 688363) closed at 43.48, down 1.29% with a trading volume of 24,700 hands, totaling 108 million yuan [1] - Ai Meike (code: 300896) closed at 142.29, down 1.46% with a trading volume of 28,000 hands, totaling 400 million yuan [1] Group 3: Fund Flow Analysis - Jinbo Biological saw a main fund net inflow of 6.66 million yuan, with a main fund net ratio of 3.05% [2] - ST Meigu experienced a main fund net outflow of 1.76 million yuan, with a net inflow from retail investors of 2.50 million yuan [2] - Huaxi Biological had a main fund net outflow of 14.61 million yuan, with a retail net inflow of 6.11 million yuan [2] - Ai Meike faced a significant main fund net outflow of 48.42 million yuan, while retail investors contributed a net inflow of 30.84 million yuan [2]

Group 1 - China Merchants Securities maintains an "Accumulate" rating for JD Health (06618.HK), highlighting its "medicine + pharmacy" dual-driven model and leading market share in retail pharmacies, with O2O delivery times as fast as 9 minutes [1] - China Everbright Securities International maintains an "Accumulate" rating for Biren Technology (06082.HK), noting its position as the first company in China to use 2.5D chip packaging technology and its strong commercial progress with over 2 billion yuan in unfulfilled orders [1] - Huachuang Securities maintains a "Strong Buy" rating for Hesai Technology (02525.HK), emphasizing its leadership in the global LiDAR market and significant cost reductions achieved through self-developed chips, with a delivery target of 200,000 units by 2025 [1] Group 2 - CICC maintains an "Outperform" rating for Haidilao (06862.HK), reporting stable table turnover rates in H2 and better-than-expected cost optimization, with new brand strategies accelerating growth [2] - CICC maintains an "Outperform" rating for Shuangdeng Co. (06960.HK), identifying it as a leader in communication and data center energy storage, benefiting from increased capital expenditure in global AIDC and the trend of lithium battery replacing lead-acid [2] Group 3 - CITIC Securities maintains a "Buy" rating for Kintor Group (00148.HK), noting the positive impact of price increases on its CCL business and the expected growth in PCB business volume [3] - CITIC Securities maintains a "Buy" rating for Shougang Resources (00639.HK), highlighting its resource scarcity and leading cost control, with expected performance growth amid rising coking coal prices in 2026-27 [3] - Shenwan Hongyuan maintains a "Buy" rating for Beautiful Garden Medical Health (02373.HK), emphasizing its accelerated industry consolidation through acquisitions and a significant increase in store numbers [3] - China Merchants Securities maintains an "Accumulate" rating for Baiguoyuan Group (02411.HK), noting its stock incentive plan and strategic upgrades aimed at restoring same-store growth and opening pace [3]

Group 1 - The medical beauty sector experienced a decline of 0.49% on December 22, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3917.36, up by 0.69%, while the Shenzhen Component Index closed at 13332.73, up by 1.47% [1] - A detailed table of individual stock performance in the medical beauty sector is provided [1] Group 2 - In terms of capital flow, the medical beauty sector saw a net outflow of 63.79 million yuan from main funds, while retail funds had a net inflow of 15.31 million yuan [2] - The net inflow from speculative funds was 48.47 million yuan [2] - A detailed table of capital flow for individual stocks in the medical beauty sector is included [2]

齐鲁晚报·齐鲁壹点记者 徐田田 12月19日，山东省消费者协会与山东省民营整形美容协会在济南联合召开媒体通气会，发布《承诺效果 型医疗美容消费争议解决指南》，介绍相关内容，解读规则亮点。山东省消费者协会、山东省民营整形 美容协会，部分行业机构代表及新闻媒体出席会议。据悉，该《指南》是目前针对医美领域因承诺效果 引发纠纷所制定的首份系统性、可操作性解决指南。 发布会上，山东省消费者协会介绍，近年来医疗美容行业快速发展，已成为消费升级的重要领域，但与 此同时，医美消费纠纷也日益增多，特别是因承诺效果引发的消费争议，由于处理依据不清晰、鉴定困 难、调解周期长，成为消费者维权难点和社会关注热点。这类争议不仅损害消费者合法权益，也扰乱行 业公平竞争秩序。此次省消费者协会联合省民营整形美容协会制定《指南》，旨在引导消费者理性看待 医美效果、避免轻信绝对化承诺，并为消费者提供多元维权路径；同时强化经营者主体责任，规范经营 行为，从源头遏制虚假宣传、模糊承诺等行业乱象；此外，《指南》也将为医美行业立标赋能，助力其 健康有序发展。 山东省民营整形美容协会副会长兼秘书长吴洪树在解读《指南》亮点时指出，《指南》遵循"事前预防 —事 ...

证券之星消息，12月19日医疗美容板块较上一交易日上涨2.13%，爱美客领涨。当日上证指数报收于 3890.45，上涨0.36%。深证成指报收于13140.22，上涨0.66%。医疗美容板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300896 | 爱美客 | 145.80 | 2.81% | 4.06万 | | 5.8716 | | 920982 | 锦波生物 | 251.98 | 1.60% | 1.33万 | | 3.31亿 | | 000615 | *ST美谷 | 4.11 | 1.48% | 7.03万 | | 2875.42万 | | 688363 | 华熙生物 | 44.18 | 1.28% | 3.23万 | | 1.43亿 | | 代码 | 名称 | | | 主力净流入（元） 主力净占比 游资净流入（元） 游资净占比 散户净流入（元） 散户净占比 | | | | | --- | --- | --- | --- | --- | --- | ...

Group 1 - The medical beauty sector experienced a decline of 0.27% compared to the previous trading day, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3876.37, up 0.16%, while the Shenzhen Component Index closed at 13053.98, down 1.29% [1] - The net inflow of main funds into the medical beauty sector was 253,500 yuan, while retail investors saw a net outflow of 701,410 yuan [2] Group 2 - The sector saw a net inflow of 676,060 yuan from speculative funds [2] - Detailed fund flow data for individual stocks in the medical beauty sector is available in the accompanying table [2]

证券之星消息，12月17日医疗美容板块较上一交易日上涨1.01%，华熙生物领涨。当日上证指数报收于 3870.28，上涨1.19%。深证成指报收于13224.51，上涨2.4%。医疗美容板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日医疗美容板块主力资金净流出2172.96万元，游资资金净流入587.9万元，散户 资金净流入1585.07万元。医疗美容板块个股资金流向见下表： ...

从资金流向上来看，当日医疗美容板块主力资金净流入6532.5万元，游资资金净流出1191.11万元，散户 资金净流出5341.39万元。医疗美容板块个股资金流向见下表： 证券之星消息，12月16日医疗美容板块较上一交易日上涨0.98%，爱美客领涨。当日上证指数报收于 3824.81，下跌1.11%。深证成指报收于12914.67，下跌1.51%。医疗美容板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300896 | 爱美客 | 140.56 | 2.02% | 4.62万 | 6.53 Z | | 688363 | 华熙生物 | 43.29 | -0.07% | 3.98万 | 1.74亿 | | 920982 | 锦波生物 | 262.15 | -0.32% | 1.66万 | 4.44 Z | | 000615 | *ST美谷 | 4.09 | -1.45% | 5.75万 | 2369.06万 | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备31010 ...

Group 1 - The medical beauty sector experienced a decline of 2.27% on December 15, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3867.92, down 0.55%, while the Shenzhen Component Index closed at 13112.09, down 1.1% [1] - A detailed table of individual stock performance in the medical beauty sector is provided [1] Group 2 - In terms of capital flow, the medical beauty sector saw a net outflow of 48.24 million yuan from main funds, while retail investors contributed a net inflow of 53.44 million yuan [2] - The net outflow from speculative funds was 5.20 million yuan [2] - A detailed table of capital flow for individual stocks in the medical beauty sector is included [2]

Group 1 - The medical beauty sector experienced a decline of 0.49% on December 12, with Huaxi Bio leading the drop [1] - The Shanghai Composite Index closed at 3889.35, up 0.41%, while the Shenzhen Component Index closed at 13258.33, up 0.84% [1] - A detailed table of individual stock performance in the medical beauty sector is provided [1] Group 2 - On the same day, the medical beauty sector saw a net outflow of 123 million yuan from major funds, while retail investors contributed a net inflow of 113 million yuan [2] - The net inflow from speculative funds was 9.98 million yuan [2] - A detailed table of fund flows for individual stocks in the medical beauty sector is included [2]